Literature DB >> 26786838

Recent Progress in Therapeutic Strategies for Ischemic Stroke.

Toru Yamashita1, Koji Abe.   

Abstract

Possible strategies for treating stroke include neuroprotection in the acute phase of cerebral ischemia and stem cell therapy in the chronic phase of cerebral ischemia. Previously, we have studied the temporal and spatial expression patterns of c-fos, hypoxia inducible factor-1α (HIF-1α), heat shock protein 70 (HSP70), and annexin V after 90 min of transient middle cerebral occlusion in rats and concluded that there is a time window for neuroprotection from 12 to 48 h after ischemia. In addition, we have estimated the neuroprotective effect of glial cell line-derived neurotrophic factor (GDNF) by injecting Sendai viral vector containing the GDNF gene into the postischemic brain. This Sendai virus-mediated gene transfer of GDNF showed a significant neuroprotective effect in the ischemic brain. Additionally, we have administered GDNF and hepatocyte growth factor (HGF) protein into the postischemic rat brain and estimated the infarct size and antiapoptotic and antiautophagic effects. GDNF and HGF significantly reduced infarct size, the number of microtubule-associated protein 1 light chain 3 (LC3)-positive cells, and the number of terminal deoxynucleotidyl transferase-mediated dUTP-biotin in situ nick-end labeling (TUNEL)-positive cells, indicating that GDNF and HGF were greatly associated with not only the antiapoptotic effect but also the antiautophagic effects. Finally, we have previously transplanted undifferentiated iPSCs into the ipsilateral striatum and cortex at 24 h after cerebral ischemia. Histological analysis was performed at 14 and 28 days after cell transplantation, and we found that iPSCs could supply a great number of doublecortin-positive neuroblasts but also formed tridermal teratoma in the ischemic brain. Our results suggest that iPSCs have a potential to provide neural cells after ischemic brain injury if tumorigenesis is properly controlled. In the future, we will combine these strategies to develop more effective therapies for the treatment of strokes.

Entities:  

Mesh:

Substances:

Year:  2016        PMID: 26786838     DOI: 10.3727/096368916X690548

Source DB:  PubMed          Journal:  Cell Transplant        ISSN: 0963-6897            Impact factor:   4.064


  13 in total

1.  The application of the emergency green channel integrated management strategy in intravenous thrombolytic therapy for AIS.

Authors:  Hui Zhang; Bin Zhang; Jie Chen
Journal:  Am J Transl Res       Date:  2021-06-15       Impact factor: 4.060

2.  SVCT2 Promotes Neural Stem/Progenitor Cells Migration Through Activating CDC42 After Ischemic Stroke.

Authors:  Yang Yang; Kaiyuan Zhang; Xuezhu Chen; Ju Wang; Xuejiao Lei; Jun Zhong; Jishu Xian; Yulian Quan; Yongling Lu; Qianying Huang; Jingyu Chen; Hongfei Ge; Hua Feng
Journal:  Front Cell Neurosci       Date:  2019-09-19       Impact factor: 5.505

Review 3.  Crosstalk Between Autophagy and Cerebral Ischemia.

Authors:  Yulin Sun; Yuanhan Zhu; Xiaojun Zhong; Xinle Chen; Jun Wang; Guozheng Ying
Journal:  Front Neurosci       Date:  2019-01-14       Impact factor: 4.677

Review 4.  Potential Mechanisms and Perspectives in Ischemic Stroke Treatment Using Stem Cell Therapies.

Authors:  Guoyang Zhou; Yongjie Wang; Shiqi Gao; Xiongjie Fu; Yang Cao; Yucong Peng; Jianfeng Zhuang; Junwen Hu; Anwen Shao; Lin Wang
Journal:  Front Cell Dev Biol       Date:  2021-04-01

5.  Mechanism of Sanhua Decoction in the Treatment of Ischemic Stroke Based on Network Pharmacology Methods and Experimental Verification.

Authors:  Shan-Shan Gao; Zi-Han Gong; Wen-Jie Li; Ji-Jia Sun; Ming-Jie Sun
Journal:  Biomed Res Int       Date:  2022-01-21       Impact factor: 3.411

Review 6.  Chemical Conditioning as an Approach to Ischemic Stroke Tolerance: Mitochondria as the Target.

Authors:  Zhen Jin; Jinzi Wu; Liang-Jun Yan
Journal:  Int J Mol Sci       Date:  2016-03-08       Impact factor: 5.923

7.  Protective effect of polysaccharide peptide on cerebral ischemia‑reperfusion injury in rats.

Authors:  Pengcheng Xing; Ke Ma; Jun Wu; Wei Long; Donglian Wang
Journal:  Mol Med Rep       Date:  2018-10-23       Impact factor: 2.952

8.  Pathophysiology of Ganglioside GM1 in Ischemic Stroke: Ganglioside GM1: A Critical Review.

Authors:  Wenchao Zhang; Paul R Krafft; Tianlong Wang; John H Zhang; Li Li; Jiping Tang
Journal:  Cell Transplant       Date:  2019-01-22       Impact factor: 4.064

9.  Eupafolin alleviates cerebral ischemia/reperfusion injury in rats via blocking the TLR4/NF‑κB signaling pathway.

Authors:  Xingwang Chen; Zhijun Yao; Xian Peng; Long Wu; Huachu Wu; Yuantong Ou; Jianbo Lai
Journal:  Mol Med Rep       Date:  2020-10-26       Impact factor: 2.952

10.  Oleanolic Acid Alleviates Cerebral Ischemia/Reperfusion Injury via Regulation of the GSK-3β/HO-1 Signaling Pathway.

Authors:  Kaili Lin; Zhang Zhang; Zhu Zhang; Peili Zhu; Xiaoli Jiang; Ying Wang; Qiudi Deng; Ken Kin Lam Yung; Shiqing Zhang
Journal:  Pharmaceuticals (Basel)       Date:  2021-12-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.